CELULARITY - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87862993
Serial Number
87862993
Registration Number
6102576
Word Mark
CELULARITY
Status
700 - Registered
Status Date
2020-07-14
Filing Date
2018-04-04
Registration Number
6102576
Registration Date
2020-07-14
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2018-11-13
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
FALK, JONATHAN ROBERT
Statements
Goods and Services
Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells
Goods and Services
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, namely, for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
Goods and Services
Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing technical writing and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biological research, namely, biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-04-12
Primary Code
042
First Use Anywhere Date
2018-02-21
First Use In Commerce Date
2018-02-21
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Camille M. Miller
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-04-07NEW APPLICATION ENTERED IN TRAM
2018-04-12NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-07-23ASSIGNED TO EXAMINER
2018-07-24NON-FINAL ACTION WRITTEN
2018-07-24NON-FINAL ACTION E-MAILED
2018-07-24NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-08-09TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-08-09CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-08-09TEAS/EMAIL CORRESPONDENCE ENTERED
2018-08-14APPROVED FOR PUB - PRINCIPAL REGISTER
2018-08-23ASSIGNED TO LIE
2018-09-11WITHDRAWN FROM PUB - OG REVIEW QUERY
2018-09-13PREVIOUS ALLOWANCE COUNT WITHDRAWN
2018-10-02NON-FINAL ACTION WRITTEN
2018-10-02NON-FINAL ACTION E-MAILED
2018-10-02NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-10-03TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-10-03CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-10-03TEAS/EMAIL CORRESPONDENCE ENTERED
2018-10-09APPROVED FOR PUB - PRINCIPAL REGISTER
2018-10-09LAW OFFICE PUBLICATION REVIEW COMPLETED
2018-10-24NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-11-13PUBLISHED FOR OPPOSITION
2018-11-13OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-01-08NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2019-06-07TEAS EXTENSION RECEIVED
2019-06-07EXTENSION 1 FILED
2019-06-07EXTENSION 1 GRANTED
2019-06-11NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-10-28TEAS STATEMENT OF USE RECEIVED
2019-11-08CASE ASSIGNED TO INTENT TO USE PARALEGAL
2019-10-28USE AMENDMENT FILED
2019-11-08STATEMENT OF USE PROCESSING COMPLETE
2019-12-04SU - NON-FINAL ACTION - WRITTEN
2019-12-04NON-FINAL ACTION E-MAILED
2019-12-04NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-04-28TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-04-30CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-04-30TEAS/EMAIL CORRESPONDENCE ENTERED
2020-05-22SU - FINAL REFUSAL - WRITTEN
2020-05-22FINAL REFUSAL E-MAILED
2020-05-22NOTIFICATION OF FINAL REFUSAL EMAILED
2020-05-26TEAS REQUEST FOR RECONSIDERATION RECEIVED
2020-05-26CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-05-26TEAS/EMAIL CORRESPONDENCE ENTERED
2020-06-11ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2020-06-12NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2020-07-14REGISTERED-PRINCIPAL REGISTER
2020-10-08TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-10-08TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-10-08ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-10-08TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-10-08APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2022-01-12AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP